Your browser doesn't support javascript.
loading
Psoriasis paradójica palmoplantar secundaria al tratamiento de la colitis ulcerosa con adalimumab / Paradoxical psoriasis of the palms and soles due to treatment of ulcerative colitis with adalimumab
Benítez Yazbek, Rashid; Eimer, Lena; Suar, Lucila; Anaya, Jvier; Busso, Corina.
  • Benítez Yazbek, Rashid; Universidad Austral. Buenos Aires. AR
  • Eimer, Lena; Universidad Austral. Buenos Aires. AR
  • Suar, Lucila; Universidad Austral. Buenos Aires. AR
  • Anaya, Jvier; Universidad Austral. Buenos Aires. AR
  • Busso, Corina; Universidad Austral. Buenos Aires. AR
Dermatol. argent ; 27(2): 78-80, abr-jun 2021. il, graf
Article in Spanish | LILACS, BINACIS | ID: biblio-1367373
RESUMEN
Los anticuerpos anti-TNF-a (tumor necrosis factor alpha) se utilizan para tratar tanto la psoriasis como la enfermedad inflamatoria intestinal (EII). Sin embargo, estos fármacos han sido implicados en la ocurrencia de la psoriasis paradójica en los pacientes sin antecedentes de psoriasis que reciben tratamiento por una colitis ulcerosa (CU) y otras enfermedades autoinmunes. Se presenta el caso de un paciente de 29 años, sin antecedentes de dermatosis, que desarrolló una psoriasis palmoplantar paradójica por el uso del adalimumab que recibía por un diagnóstico de CU. El cuadro remitió al suspender el medicamento y recurrió al reiniciarlo, motivo por el cual se rotó al ustekinumab. La CU respondió satisfactoriamente, sin nuevas lesiones dermatológicas.
ABSTRACT
Anti TNF-a (tumor necrosis factor alpha) antibodies are used to treat both psoriasis and inflammatory bowel disease (IBD). However, these drugs have been implicated in the occurrence of the so-called paradoxical psoriasis in patients with no previous history of psoriasis, who receive treatment for ulcerative colitis and other autoimmune diseases. We present a 29-year-old male patient, with no previous history of dermatosis, who developed paradoxical palmar-plantar psoriasis due to the use of adalimumab that he was receiving for a diagnosis of ulcerative colitis. The condition remitted when the drug was suspended and recurred when it was restarted, and for that reason, treatment was rotated to ustekinumab. Ulcerative colitis responded satisfactorily, with no new dermatological lesions.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Psoriasis / Colitis, Ulcerative / Adalimumab / Anti-Inflammatory Agents Limits: Adult / Humans / Male Language: Spanish Journal: Dermatol. argent Journal subject: Dermatology Year: 2021 Type: Article Affiliation country: Argentina Institution/Affiliation country: Universidad Austral/AR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Psoriasis / Colitis, Ulcerative / Adalimumab / Anti-Inflammatory Agents Limits: Adult / Humans / Male Language: Spanish Journal: Dermatol. argent Journal subject: Dermatology Year: 2021 Type: Article Affiliation country: Argentina Institution/Affiliation country: Universidad Austral/AR